Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

Coming Down the Pike: Chaperones

Nov 2, 2008

Molecules called "chaperones" facilitate correct protein folding.

The Past as Prologue

Can previous trends of Democratic and Republican administrations predict industry's future?
Oct 2, 2008

Can previous trends of Democratic and Republican administrations predict industry's future?

Dirty Hands

Are hypersanitation trends a result of scaremongering or a lack of faith in medicine?
Sep 2, 2008

Are hypersanitation trends a result of scaremongering or a lack of faith in medicine?

FDA and Medicare at Odds?

Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.
Aug 2, 2008

Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.

Contract Service Providers: The State of the Market

Outsourcing strategies of large pharma companies are changing. The CEO of Patheon talks about his company's plan to meet customers' changing needs.
Aug 1, 2008

Outsourcing strategies of large pharma companies are changing. The CEO of Patheon talks about his company's plan to meet customers' changing needs.

Contract Vendors, They Are A Changin'

As pharma companies outsource new types of projects, contractors are trying to meet new needs.
Aug 1, 2008

As pharma companies outsource new types of projects, contractors are trying to meet new needs.

How to Pay for it All?

With no economic relief in sight, industry, like all of us, is grappling with high—and new—costs.
Jul 2, 2008

With no economic relief in sight, industry, like all of us, is grappling with high—and new—costs.

Coming Down the Pike: Protein-Substrate Binding

Drugmakers seeking to block the activity of a protein may have a new strategy at their disposal.
Jul 2, 2008

Drugmakers seeking to block the activity of a protein may have a new strategy at their disposal.

Coming Down the Pike: Endocannabinoids

Scientists are uncovering signaling systems that operate via cannabinoid messenger molecules.
Jun 2, 2008

Scientists are uncovering signaling systems that operate via cannabinoid messenger molecules.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here